3rd Annual MDA Insights in Research Investor Summit (IRIS) for Neuromuscular Disease
The purpose of IRIS is to provide an opportunity for companies and inventors in the neuromuscular space to showcase investment and licensing opportunities to BD teams from biotechnology and pharma and venture investors. Throughout the day, a select group of presenters, ranging from inventors to early-stage biotech and pharmaceutical companies, will have the opportunity to present in 20-minute sessions, with time set aside for Q&A after the presentation. Potential investors will have the opportunity to ask questions during the session and to connect with presenters afterwards at designated break-out areas.
Apply to be an IRIS presenter, click here.
Want to attend IRIS? Please register to attend the MDA Conference
Questions/Inquires – Contact Elizabeth Habeeb-Louks